跳至主要内容
临床试验/CTIS2023-507354-32-00
CTIS2023-507354-32-00进行中(未招募)1 期

C5471001

Pfizer Inc.0 个研究点目标入组 45 人开始时间: 2023年9月27日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Pfizer Inc.
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Pfizer Inc.

相似试验

进行中(未招募)
1 期
A Study to Learn About the Taste Profiles of Different Suspensions of Study Medicine Called PF-07923568 in Healthy Adult ParticipantsRSV (respiratory syncytial virus)MedDRA version: 21.1Level: PTClassification code: 10061603Term: Respiratory syncytial virus infection Class: 100000004862
CTIS2023-504924-24-00Pfizer Inc.12
进行中(未招募)
1 期
A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredientscoronavirus disease 2019MedDRA version: 23.0Level: LLTClassification code: 10084382Term: Coronavirus disease 2019 Class: 10021881
CTIS2023-506442-24-00Pfizer Inc.12
进行中(未招募)
1 期
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy AdultsType 2 Diabetes Mellitus, Obesity, Overweight managementMedDRA version: 20.0Level: PTClassification code: 10029883Term: Obesity Class: 100000004861MedDRA version: 24.1Level: PTClassification code: 10033307Term: Overweight Class: 100000004861MedDRA version: 20.0Level: PTClassification code: 10012601Term: Diabetes mellitus Class: 100000004861
CTIS2024-513863-21-00Pfizer Inc.16
招募中
1 期
An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin deltaInfertility in women undergoing assisted reproductive technologies (ART)
CTIS2023-508149-42-00Ferring Pharmaceuticals A/S200
进行中(未招募)
1 期
To Study the Safety and Pharmacokinetics of BLYG8824A in Patients with Locally Advanced or Metastatic Colorectal Cancersocally Advanced or Metastatic Colorectal Cancers (mCRC)MedDRA version: 27.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864
CTIS2023-503409-12-00Genentech Inc.58